Radiofrequency ablation of Bethesda category III thyroid nodules with benign molecular testing: Preliminary findings from a single institution

Ryu, Y. J., Hsu, S. Y., Kuo, E. J., Liou, R., McManus, C. M., Lee, J. A., & Kuo, J. H. (2024). Radiofrequency ablation of Bethesda category III thyroid nodules with benign molecular testing: Preliminary findings from a single institution. The American Journal of Surgery, 115929. https://doi.org/10.1016/j.amjsurg.2024.115929
Authors:
Young Jae Ryu
Shawn Y Hsu
Eric J Kuo
Rachel Liou
Catherine M McManus
James A Lee
Jennifer H Kuo
Affiliated Authors:
Young Jae Ryu
Shawn Y Hsu
Eric J Kuo
Rachel Liou
Catherine M McManus
James A Lee
Jennifer H Kuo
Author Keywords:
radiofrequency ablation
thyroid nodule
atypia of undetermined significance
molecular testing
Publication Type:
Article
Unique ID:
10.1016/j.amjsurg.2024.115929
PMID:
Publication Date:
Data Source:
PubMed

Record Created: